3SBIO (01530) intends to appoint KPMG as its new auditor

date
21:01 26/05/2026
avatar
GMT Eight
Sansei Pharmaceuticals (01530) announced that, after considering that Ernst & Young, the company's auditor, has been serving for over 15 years, they have decided to hire a new auditor with equivalent qualifications to conduct audits for the company and its subsidiaries (referred to as the "Group") in the coming years, in order to better align with good corporate practices.
3SBIO (01530) announces that after considering that Ernst & Young LLP (EY) has been serving as the Company's auditor for over 15 years, appointing a new auditor with equivalent qualifications to conduct audits for the Company and its subsidiaries (collectively, the "Group") in the coming years would be in line with good corporate practices. Based on the recommendation of the Company's Audit Committee, the Board has passed a resolution to propose at the upcoming Annual General Meeting of Shareholders in 2026 (the "2026 AGM") to approve the appointment of KPMG LLP as the Company's new auditor, with a term from the end of the 2026 AGM to the end of the Company's next AGM, subject to approval by the Company's shareholders. EY will retire as the Company's auditor at the end of the 2026 AGM and will not be reappointed. In assessing KPMG's qualifications and capabilities, the Audit Committee reviewed KPMG's credentials and determined that KPMG possesses the necessary qualifications and capabilities (including industry knowledge, technical expertise, personnel, time, and other resources) to fulfill the auditor's responsibilities for the Company. Specifically, the Audit Committee evaluated the following aspects: KPMG's proposed audit plan and fees; KPMG's experience, knowledge, and technical capabilities in handling audits of Hong Kong Stock Exchange listed companies; KPMG's independence and objectivity towards the Group; KPMG's market reputation and track record; KPMG's resources and other capabilities; and guidance issued by the Financial Reporting Council. Given KPMG's aforementioned qualities, the Board believes that appointing KPMG as the Company's auditor, as recommended by the Audit Committee, is in the overall interest of the Company and its shareholders.